The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

President’s Cancer Panel calls for urgent action on drug prices

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Urgent action must be taken to address the dramatic rise of cancer drug prices and to better align prices with value, the President’s Cancer Panel urged in a recent report.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Clinical

Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer

A story is told that after first obtaining approval for marketing Premarin in 1942, Wyeth Laboratories didn’t lock up the secret recipe for making the hormonal drug in a company safe, to be guarded by patent lawyers.
By Claire Marie Porter
Sponsored

Opening doors to immunotherapy in prostate cancer: A roadmap from clinic to community

Prostate cancer remains a formidable challenge, particularly in its advanced stages, where bone metastases and treatment resistance dominate outcomes. At City of Hope, our focus is on leveraging immunotherapy to transform this landscape.
By Tanya Dorff
In the Archives

Bernie Lewinsky’s collection of artifacts captures “the learning curve” of radiation oncology

Over his five decades as a radiation oncologist, Bernie Lewinsky has been collecting the relics of radiotherapy.
By Sara Willa Ernst
Cancer Policy

NIH ends fetal tissue research—again

NIH will no longer fund scientific research that uses human fetal tissue from elective abortions, a practice that has contributed to the study of cancer, the development of vaccines, and the treatment of other diseases. 
By Sara Willa Ernst
Cancer Policy

ACA Marketplace enrollments down by 1.4 million, early data shows

According to a preliminary tally, 1.4 million fewer Americans have signed up for health insurance through the Affordable Care Act Marketplace this year, according to early data published by the Centers for Medicare and Medicaid Services. 
By Sara Willa Ernst
Cancer Policy

Workforce shortages will threaten access to cancer care, President’s Cancer Panel says in a report

The U.S. cancer workforce faces critical challenges that may affect Americans’ access to lifesaving cancer care and delay progress in cancer research. 
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account